Sex Differences in Ethanol’s Anxiolytic Effect and Chronic Ethanol Withdrawal Severity in Mice with a Null Mutation of the 5α-Reductase Type 1 Gene

Behavior Genetics

Volumn 45, Issue 3, 2015, Pages 354-367

  Tanchuck Nipper, Michelle A ^a   Ford, Matthew M ^a,b   Hertzberg, Anna ^a   Beadles Bohling, Amy ^a   Cozzoli, Debra K ^a   Finn, Deborah A ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Alcohol; Allopregnanolone; GABA; Hypnosis; Metabolism; Neurosteroid

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; CORTICOSTERONE; ELTANOLONE; MEMBRANE PROTEIN; SRD5A1 PROTEIN, MOUSE; STEROID 5ALPHA REDUCTASE;

ANIMAL; ANIMAL BEHAVIOR; BLOOD; DRINKING BEHAVIOR; FEMALE; GENE DELETION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; MALE; MAZE TEST; MOUSE; MUTATION; PHYSIOLOGY; SEX DIFFERENCE; SEXUAL DEVELOPMENT; WITHDRAWAL SYNDROME;

3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE; ALCOHOL DRINKING; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CORTICOSTERONE; ETHANOL; FEMALE; GENE DELETION; GENOTYPE; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MUTATION; PREGNANOLONE; SEX CHARACTERISTICS; SEX FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84937771313     PISSN: 00018244     EISSN: 15733297     Source Type: Journal    
DOI: 10.1007/s10519-014-9691-5     Document Type: Article

References (68)

1. Alele PE, Devaud LL (2007) Sex differences in steroid modulation of ethanol withdrawal in male and female rats. J Pharmacol Exp Ther 320:427–436
2. Barbaccia ML, Affricano D, Trabucchi M, Purdy RH, Colombo G, Agabio R, Gessa GL (1999) Ethanol markedly increases ‘GABAergic’ neurosteroids in alcohol-preferring rats. Eur J Pharmacol 384:R1–R2
3. A receptor. Nature Rev Neurosci 6:565–575
4. Bergeson SE, Warren RK, Crabbe JC, Metten P, Erwin VG, Belknap JK (2003) Chromosomal loci influencing chronic ethanol withdrawal severity. Mamm Genome 14:454–463
5. Blednov YA, Walker DL, Iyer SV, Homanics G, Harris RA (2010) Mice lacking Gad2 show altered behavioral effects of ethanol, flurazepam and gabaxadol. Addict Biol 15:45–61
6. Boyd KN, Kumar S, O’Buckley TK, Morrow AL (2010) Chronic ethanol exposure produces tolerance to elevations in neuroactive steroids: mechanisms and reversal by exogenous ACTH. J Neurochem 115:142–152
7. Browman KE, Crabbe JC (2000) Quantitative trait loci affecting ethanol sensitivity in BXD recombinant inbred mice. Alcohol Clin Exp Res 24:17–23
8. Cagetti E, Pinna G, Guidotti A, Baicy K, Olsen RW (2004) Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology 46:570–579
9. Celotti F, Negri-Cesi P, Poletti A (1997) Steroid metabolism in the mammalian brain: 5alpha-reduction and aromatization. Brain Res Bull 44:365–375
10. Crabbe JC (1998) Provisional mapping of quantitative trait loci for chronic ethanol withdrawal severity in BXD recombinant inbred mice. J Pharmacol Exp Ther 286:263–271
11. Crabbe JC, Feller DJ, Dorow J (1989) Sensitivity and tolerance to ethanol-induced hypothermia in genetically selected mice. J Pharmacol Exp Ther 49:456–461
12. Dazzi L, Serra M, Seu E, Cherchi G, Pisu MG, Purdy RH, Biggio G (2002) Progesterone enhances ethanol-induced modulation of mesocortical dopamine neurons: antagonism by finasteride. J Neurochem 83:1103–1109
13. Devaud LL, Chadda R (2001) Sex differences in rats in the development of and recovery from ethanol dependence assessed by changes in seizure susceptibility. Alcohol Clin Exp Res 25:1689–1696
14. 1R/LacZ transgenic mice. J Neurochem 104:1043–1054
15. Finn DA, Crabbe JC (1999) Chronic ethanol differentially alters susceptibility to chemically induced convulsions in withdrawal seizure-prone and –resistant mice. J Pharmacol Exp Ther 288:782–790
16. Finn DA, Gee KW (1994) The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther 271:164–170
17. Finn DA, Purdy RH (2007) Neuroactive steroids in anxiety and stress. In: Sibley DR, Hanin I, Kuhar M, Skolnick P (eds) Handbook of contemporary neuropharmacology, vol 2. Wiley & Sons Inc, New Jersey, pp 133–176
18. Finn DA, Roberts AJ, Lotrich F, Gallaher EJ (1997) Genetic differences in behavioral sensitivity to a neuroactive steroid. J Pharmacol Exp Res 280:820–828
19. Finn DA, Gallaher EJ, Crabbe JC (2000) Differential change in neuroactive steroid sensitivity during ethanol withdrawal. J Pharmacol Exp Ther 292:394–405
20. Finn DA, Ford MM, Wiren KM, Roselli CE, Crabbe JC (2004a) The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 101:91–112
21. Finn DA, Long SL, Tanchuck MA, Crabbe JC (2004b) Interaction of chronic ethanol exposure and finasteride: sex and strain differences. Pharmacol Biochem Behav 78:435–443
22. Finn DA, Sinnott RS, Ford MM, Long SL, Tanchuck MA, Phillips TJ (2004c) Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice. Neuroscience 123:813–819
23. Finn DA, Beadles-Bohling AS, Beckley EH, Ford MM, Gililland KR, Gorin-Meyer RE, Wiren KM (2006a) A new look at the 5α-reductase inhibitor finasteride. CNS Drug Rev 12:53–76
24. Finn DA, Douglass AD, Beadles-Bohling AS, Tanchuck MA, Long SL, Crabbe JC (2006b) Selected line difference in sensitivity to a GABAergic neurosteroid during ethanol withdrawal. Genes Brain Behav 5:53–63
25. Ford MM, Nickel JD, Kaufman MN, Finn DA (2014) Null mutation of 5α-reductase type I gene alters ethanol consumption patterns in a sex-dependent manner. Behav Genet (companion article)
26. Ford MM, Nickel JD, Finn DA (2005) Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6 J mice: potential role of endogenous neurosteroids? Alcohol 37:23–33
27. Ford MM, Steele AM, McCracken AD, Finn DA, Grant KA (2013) The relationship between adjunctive drinking, blood ethanol concentration and plasma corticosterone across fixed-time intervals of food delivery in two inbred mouse strains. Psychoneuroendocrinology 38:2598–2610
28. Frye CA, Rhodes ME, Walf AA, Harney JP (2001) Testosterone reduced pentylenetetrazole-induced ictal activity of wildtype mice but not those deficient in type I 5α-reductase. Brain Res 918:182–186
29. Frye CA, Rhodes ME, Walf A, Harney J (2002a) Progesterone reduces pentylenetetrazol-induced ictal activity of wild-type but not those deficient in type I 5α-reductase. Epilepsia 43(Suppl 5):14–17
30. Frye CA, Rhodes ME, Walf A, Harney JP (2002b) Testosterone enhances aggression of wild-type mice but not those deficient in type I 5α-reductase. Brain Res 948:165–170
31. Frye CA, Walf AA, Rhodes ME, Harney JP (2004) Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5α-reductase. Brain Res 1004:116–124
32. Gasior M, Carter RB, Witkin JM (1999) Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol Sci 20:107–112
33. Gerlai R (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19:177–181
34. Gililland KR, Finn DA (2007) The impact of gonadectomy and adrenalectomy on acute withdrawal severity in male and female C57BL/6J and DBA/2J mice following a single high dose of ethanol. Alcohol Clin Exp Res 31:1846–1857
35. Gililland-Kaufman KR, Tanchuck MA, Ford MM, Crabbe JC, Beadles-Bohling AS, Snelling C, Mark GP, Finn DA (2008) The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice. Brain Res 1243:113–123
36. Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT (2005) Evaluation of GABAergic neuroactive steroid 3α-hydroxy-5α-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology 180:267–278
37. A receptor alpha 6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice. Alcohol Clin Exp Res 22:259–265
38. Jenkins EP, Hseih CL, Milantovich A, Normington K, Berman DM, Francke U, Russell DW (1991) Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 11:1102–1112
39. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2006) Ethanol-related traits in mice selectively bred for differential sensitivity to methamphetamine-induced activation. Behav Neurosci 120:1356–1366
40. Khisti RT, VanDoren MJ, O’Buckley T, Morrow AL (2003) Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Res 980:255–265
41. Khisti RT, VanDoren MJ, Matthews DB, Morrow AL (2004) Ethanol-induced elevations of 3α-hydroxy-5α-pregnan-20-one does not modulate motor incoordination in rats. Alcohol Clin Exp Res 28:1249–1256
42. Koonce CJ, Frye CA (2013) Progesterone facilitates exploration, affective and social behaviors among wildtype, but not 5α-reductase type 1 mutant, mice. Behav Brain Res 253:232–239
43. Koonce CJ, Frye CA (2014) Female mice with deletion of type one 5α-reductase have reduced reproductive responding during proestrus and after hormone priming. Pharmacol Biochem Behav 122:20–29
44. Koonce CJ, Walf AA, Frye CA (2012) Type 1 5α-reductase may be required for estrous cycle changes in affective behaviors of female mice. Behav Brain Res 226:376–380
45. A receptors in the acute and chronic effects of ethanol: a decade of progress. Psychopharmacology 205:529–654
46. Mahendroo MS, Cala KM, Russell DW (1996) 5α-reduced androgens play a key role in murine parturition. Mol Endocrinol 10:380–392
47. Mahendroo MS, Cala KM, Landrum CP, Russell DW (1997) Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess. Mol Endocr 11:917–927
48. Mahendroo MS, Porter A, Russell DW, Word RA (1999) The parturition defect in steroid 5α-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 13:981–992
49. Mahendroo MS, Cala KM, Hess DL, Russell DW (2001) Unexpected virilization in male mice lacking steroid 5α-reductase enzymes. Endocrinology 142:4652–4662
50. Melcangi RC, Poletti A, Cavarretta I, Celotti F, Colciago A, Magnaghi V, Motta M, Negri-Cesi P, Martini L (1998) The 5α-reductase in the central nervous system: expression and modes of control. J Steroid Biochem Mol Biol 65:295–299
51. Metten P, Crabbe JC (2005) Alcohol withdrawal severity in inbred mouse (Mus musculus) strains. Behav Neurosci 119:911–925
52. Morrow AL, VanDoren MJ, Fleming R, Penland S (2001) Ethanol and neurosteroid interactions in the brain. Int Rev Neurobiol 46:349–377
53. Osborne DM, Frye CA (2009) Estrogen increases latencies to seizures and levels of 5α-pregnan-3α-ol-20-one in hippocampus of wild-type, but not in 5α-reductase knockout mice. Epilepsy Behav 16:411–414
54. Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6:2311–2322
55. Porcu P, O’Buckley TK, Alward SE, Song SC, Grant KA, de Wit H, Morrow AL (2010) Differential effects of ethanol on serum GABAergic 3α,5α/3α,5β neuroactive steroids in mice, rats, cynomolgus monkeys, and humans. Alcohol Clin Exp Res 34:432–442
56. Porcu P, Locci A, Santoru F, Berretti R, Morrow AL, Concas A (2014) Failure of acute ethanol administration to alter cerebrocortical and hippocampal allopregnanolone levels in C57BL/6J and DBA/2J mice. Alcohol Clin Exp Res 38:948–958
57. Reddy DS (2010) Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 186:113–137
58. Romeo E, Brancati A, De Lorenzo A, Fucci P, Furnari C, Pompili E, Sasso GF, Spalletta G, Troisi A, Pasini A (1996) Marked decrease of plasma neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol 19:366–369
59. A receptor activity in rat hippocampus. J Neurosci 24:6521–6530
60. Snelling C, Tanchuck-Nipper MA, Ford MM, Jensen JP, Cozzoli DK, Ramaker MJ, Helms M, Crabbe JC, Rossi D, Finn DA (2014) Quantification of ten neuroactive steroids in plasma in Withdrawal Seizure–Prone and–Resistant mice during chronic ethanol withdrawal. Psychopharmacology 231:3401–3414
61. Spanagel R (2009) Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol Rev 89:649–705
62. Tanchuck MA, Long SL, Ford MM, Hashimoto J, Crabbe JC, Roselli CE, Wiren KM, Finn DA (2009) Selected line differences in the effects of ethanol dependence and withdrawal on allopregnanolone levels and 5α-reductase enzyme activity and expression. Alcohol Clin Exp Res 33:2077–2087
63. Tanchuck MA, Cozzoli DK, He I, Kaufman KR, Snelling C, Crabbe JC, Mark GP, Finn DA (2013) Local changes in neurosteroid levels in the substantia nigra reticulata and the ventral tegmental area alter chronic ethanol withdrawal severity in male Withdrawal Seizure-Prone mice. Alcohol Clin Exp Res 37:784–793
64. Terdal ES, Crabbe JC (1994) Indexing withdrawal in mice: matching genotypes for exposure in studies using ethanol vapor inhalation. Alcohol Clin Exp Res 18:542–547
65. Tokunaga S, McDaniel JR, Morrow AL, Matthews DB (2003) Effect of acute ethanol and acute allopregnanolone administration on spontaneous hippocampal pyramidal cell neural activity. Brain Res 967:273–280
66. VanDoren MJ, Matthews DB, Janis GC, Grobin AC, Devaud LL, Morrow AL (2000) Neuroactive steroid 3α-hydroxy-5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J Neurosci 20:1982–1989
67. Veatch LM, Writght TM, Randall CL (2007) Only male mice show sensitization of handling-induced convulsions across repeated ethanol withdrawal cycles. Alcohol Clin Exp Res 31:477–485
68. Wolfer DP, Crusio WE, Lipp HP (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25:336–340